282 related articles for article (PubMed ID: 17878353)
21. [Kv1.3 potassium channel expression changes after CD4(+) and subsets CD28(null)/CD28(+)T cells activation in peripheral blood of patients with acute coronary syndrome].
Feng DY; Zhang CT; Ma YX; Zhou HL; Xu RD; Yang XW; Huang S; Ma J; Quan XQ
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jul; 37(7):599-604. PubMed ID: 19961728
[TBL] [Abstract][Full Text] [Related]
22. Curcumin serves as a human kv1.3 blocker to inhibit effector memory T lymphocyte activities.
Lian YT; Yang XF; Wang ZH; Yang Y; Yang Y; Shu YW; Cheng LX; Liu K
Phytother Res; 2013 Sep; 27(9):1321-7. PubMed ID: 23132777
[TBL] [Abstract][Full Text] [Related]
23. Targeting effector memory T-cells with Kv1.3 blockers.
Wulff H; Pennington M
Curr Opin Drug Discov Devel; 2007 Jul; 10(4):438-45. PubMed ID: 17659485
[TBL] [Abstract][Full Text] [Related]
24. Immunosuppressive evidence of Tityus serrulatus toxins Ts6 and Ts15: insights of a novel K(+) channel pattern in T cells.
Pucca MB; Bertolini TB; Cerni FA; Bordon KC; Peigneur S; Tytgat J; Bonato VL; Arantes EC
Immunology; 2016 Feb; 147(2):240-50. PubMed ID: 26595158
[TBL] [Abstract][Full Text] [Related]
25. Blocking KV1.3 channels inhibits Th2 lymphocyte function and treats a rat model of asthma.
Koshy S; Huq R; Tanner MR; Atik MA; Porter PC; Khan FS; Pennington MW; Hanania NA; Corry DB; Beeton C
J Biol Chem; 2014 May; 289(18):12623-32. PubMed ID: 24644290
[TBL] [Abstract][Full Text] [Related]
26. Differentially Expressed Potassium Channels Are Associated with Function of Human Effector Memory CD8
Sim JH; Kim KS; Park H; Kim KJ; Lin H; Kim TJ; Shin HM; Kim G; Lee DS; Park CW; Lee DH; Kang I; Kim SJ; Cho CH; Doh J; Kim HR
Front Immunol; 2017; 8():859. PubMed ID: 28791017
[TBL] [Abstract][Full Text] [Related]
27. The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain.
Rus H; Pardo CA; Hu L; Darrah E; Cudrici C; Niculescu T; Niculescu F; Mullen KM; Allie R; Guo L; Wulff H; Beeton C; Judge SI; Kerr DA; Knaus HG; Chandy KG; Calabresi PA
Proc Natl Acad Sci U S A; 2005 Aug; 102(31):11094-9. PubMed ID: 16043714
[TBL] [Abstract][Full Text] [Related]
28. Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases.
Beeton C; Wulff H; Standifer NE; Azam P; Mullen KM; Pennington MW; Kolski-Andreaco A; Wei E; Grino A; Counts DR; Wang PH; LeeHealey CJ; S Andrews B; Sankaranarayanan A; Homerick D; Roeck WW; Tehranzadeh J; Stanhope KL; Zimin P; Havel PJ; Griffey S; Knaus HG; Nepom GT; Gutman GA; Calabresi PA; Chandy KG
Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17414-9. PubMed ID: 17088564
[TBL] [Abstract][Full Text] [Related]
29. Potassium channel-blockers as therapeutic agents to interfere with bone resorption of periodontal disease.
Valverde P; Kawai T; Taubman MA
J Dent Res; 2005 Jun; 84(6):488-99. PubMed ID: 15914584
[TBL] [Abstract][Full Text] [Related]
30. Targeting effector memory T cells with the small molecule Kv1.3 blocker PAP-1 suppresses allergic contact dermatitis.
Azam P; Sankaranarayanan A; Homerick D; Griffey S; Wulff H
J Invest Dermatol; 2007 Jun; 127(6):1419-29. PubMed ID: 17273162
[TBL] [Abstract][Full Text] [Related]
31. The D-diastereomer of ShK toxin selectively blocks voltage-gated K+ channels and inhibits T lymphocyte proliferation.
Beeton C; Smith BJ; Sabo JK; Crossley G; Nugent D; Khaytin I; Chi V; Chandy KG; Pennington MW; Norton RS
J Biol Chem; 2008 Jan; 283(2):988-97. PubMed ID: 17984097
[TBL] [Abstract][Full Text] [Related]
32. Dynamic differentiation of activated human peripheral blood CD8+ and CD4+ effector memory T cells.
Schwendemann J; Choi C; Schirrmacher V; Beckhove P
J Immunol; 2005 Aug; 175(3):1433-9. PubMed ID: 16034079
[TBL] [Abstract][Full Text] [Related]
33. Analogs of the sea anemone potassium channel blocker ShK for the treatment of autoimmune diseases.
Beeton C; Pennington MW; Norton RS
Inflamm Allergy Drug Targets; 2011 Oct; 10(5):313-21. PubMed ID: 21824083
[TBL] [Abstract][Full Text] [Related]
34. Modulation of Kv channel expression and function by TCR and costimulatory signals during peripheral CD4(+) lymphocyte differentiation.
Liu QH; Fleischmann BK; Hondowicz B; Maier CC; Turka LA; Yui K; Kotlikoff MI; Wells AD; Freedman BD
J Exp Med; 2002 Oct; 196(7):897-909. PubMed ID: 12370252
[TBL] [Abstract][Full Text] [Related]
35. The role of T cell potassium channels, KV1.3 and KCa3.1, in the inflammatory cascade in ulcerative colitis.
Hansen LK
Dan Med J; 2014 Nov; 61(11):B4946. PubMed ID: 25370966
[TBL] [Abstract][Full Text] [Related]
36. Normal human CD4(+) helper T cells express Kv1.1 voltage-gated K(+) channels, and selective Kv1.1 block in T cells induces by itself robust TNFα production and secretion and activation of the NFκB non-canonical pathway.
Fellerhoff-Losch B; Korol SV; Ganor Y; Gu S; Cooper I; Eilam R; Besser M; Goldfinger M; Chowers Y; Wank R; Birnir B; Levite M
J Neural Transm (Vienna); 2016 Mar; 123(3):137-57. PubMed ID: 26611796
[TBL] [Abstract][Full Text] [Related]
37. Lovastatin blocks Kv1.3 channel in human T cells: a new mechanism to explain its immunomodulatory properties.
Zhao N; Dong Q; Qian C; Li S; Wu QF; Ding D; Li J; Wang BB; Guo KF; Xie JJ; Cheng X; Liao YH; Du YM
Sci Rep; 2015 Nov; 5():17381. PubMed ID: 26616555
[TBL] [Abstract][Full Text] [Related]
38. The anti-proliferative effect of cation channel blockers in T lymphocytes depends on the strength of mitogenic stimulation.
Petho Z; Balajthy A; Bartok A; Bene K; Somodi S; Szilagyi O; Rajnavolgyi E; Panyi G; Varga Z
Immunol Lett; 2016 Mar; 171():60-9. PubMed ID: 26861999
[TBL] [Abstract][Full Text] [Related]
39. Potassium channel changes of peripheral blood T-lymphocytes from Kazakh hypertensive patients in Northwest China and the inhibition effect towards potassium channels by telmisartan.
Zhang Q; Gou F; Zhang Y; He Y; He J; Peng L; Cheng L; Yuan Q; Zhang G; Huang S
Kardiol Pol; 2016; 74(5):476-488. PubMed ID: 26502942
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory effects of candesartan on KCa3.1 potassium channel expression and cell culture and proliferation in peripheral blood CD4
Li H; Zhao JL; Zhang YM; Han SX
Clin Exp Hypertens; 2018; 40(4):303-311. PubMed ID: 29388859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
